Conagra Brands, Inc. CAG is likely to register a top- and bottom-line decline when it reports fourth-quarter fiscal 2024 earnings on Jul 11. The Zacks Consensus Estimate for net sales is pegged at $2.9 billion, suggesting a decline of 1.2% from the prior-year quarter’s reported figure. The consensus mark for the fiscal 2024 top line is pegged at $12.1 billion, indicating a decline of 1.6% from the year-ago period’s reported figure. The consensus mark for quarterly earnings has moved down by a penny in the past 30 days to 56 cents per share. This indicates a decline of 9.7% from the year-ago quarter’s reported figure. The consensus mark for the fiscal 2024 bottom line is pegged at $2.62 per share, suggesting a decline of 5.4% from the year-ago period’s reported figure. CAG has a trailing four-quarter earnings surprise of 6.8%, on average. Factors To Note CAG has been facing cost inflation, which is squeezing its margin performance. The company is experiencing higher spending on advertising and promotions (A&P). These trends are likely to have impacted the company’s profitability in the to-be-reported quarter. Our model suggests an A&P expenses increase of 17.2% in the fiscal fourth quarter. For the fiscal 2024, management envisions an adjusted earnings per share (EPS) of $2.60-$2.65, suggesting a year-over-year decline. The company expects an annual adjusted operating margin of 15.8%. The company is also battling sluggish volumes due to an industry-wide slowdown in consumption. Macroeconomic challenges are adversely impacting consumer purchasing patterns. Our model suggests volume declines of 1.2% for the fourth quarter and 3.1% for the fiscal 2024. Management anticipates an organic net sales decline of 1-2% in the fiscal 2024. What the Zacks Model Unveils Our proven model predicts an earnings beat for Conagra this time around. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the odds of an earnings beat. You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter. Conagra carries a Zacks Rank #3 and has an Earnings ESP of +2.78%. Other Stocks With the Favorable Combination Here are some companies worth considering, as our model shows that these, too, have the right combination of elements to beat on earnings this reporting cycle. Kimberly-Clark Corporation KMB currently has an Earnings ESP of +2.25% and a Zacks Rank #3. The company is likely to register a decline in the top line when it reports second-quarter 2024 numbers. The consensus mark for revenues is pegged at $5.08 billion, which suggests a drop of 1.1% from the figure reported in the year-ago quarter. You can see the complete list of today’s Zacks #1 Rank stocks here. The Zacks Consensus Estimate for Kimberly-Clark’s quarterly earnings per share of $1.67 suggests a 1.2% increase from the year-ago quarter. KMB has a trailing four-quarter earnings surprise of 11.3%, on average. Clorox CLX currently has an Earnings ESP of +2.14% and a Zacks Rank of 3. The company is likely to register a top- and bottom-line decline when it reports fourth-quarter fiscal 2024 numbers. The Zacks Consensus Estimate for Clorox’s quarterly revenues is pegged at $1.98 billion, calling for a decline of almost 2% from the figure reported in the prior-year quarter. The Zacks Consensus Estimate for Clorox’s quarterly earnings of $1.53 suggests a drop of 8.4% from the year-ago quarter’s levels. However, Clorox has a trailing four-quarter earnings surprise of 128.5%, on average. Domino's Pizza, Inc. DPZ currently has an Earnings ESP of +6.00% and a Zacks Rank of 3. The Zacks Consensus Estimate for second-quarter fiscal 2024 earnings per share is pegged at $3.66, suggesting 18.8% growth year over year. The Zacks Consensus Estimate for Domino's Pizza’s quarterly revenues is pegged at $1.1 billion, indicating a rise of 7.8% from the figure reported in the prior-year quarter. DPZ has a trailing four-quarter earnings surprise of 9.3%, on average. Stay on top of upcoming earnings announcements with the Zacks Earnings Calendar. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Domino's Pizza Inc (DPZ):Free Stock Analysis Report Kimberly-Clark Corporation (KMB):Free Stock Analysis Report The Clorox Company (CLX):Free Stock Analysis Report Conagra Brands (CAG):Free Stock Analysis Report To read this article on Zacks.com click here. Zacks Investment Research
Conagra Brands (CAG) Q4 Earnings Coming Up: Factors to Note
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more
Start Your Free Trial Now!Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...